Bicocca Open Archive

Logo unimib boa
STRAZZABOSCO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.074
AS - Asia 15.066
EU - Europa 11.026
SA - Sud America 2.080
AF - Africa 335
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 34
Totale 58.652
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.276
SG - Singapore 5.335
CN - Cina 3.430
HK - Hong Kong 2.134
VN - Vietnam 1.984
RU - Federazione Russa 1.930
SE - Svezia 1.635
CA - Canada 1.632
BR - Brasile 1.557
IT - Italia 1.494
DE - Germania 1.351
IE - Irlanda 1.251
UA - Ucraina 1.151
GB - Regno Unito 676
FR - Francia 471
IN - India 443
FI - Finlandia 381
KR - Corea 317
BD - Bangladesh 240
AR - Argentina 202
TR - Turchia 190
IQ - Iraq 181
AT - Austria 121
ZA - Sudafrica 118
NL - Olanda 109
DK - Danimarca 106
ID - Indonesia 104
MX - Messico 104
PK - Pakistan 104
JP - Giappone 100
SA - Arabia Saudita 80
ES - Italia 77
EC - Ecuador 76
CO - Colombia 70
PH - Filippine 65
PL - Polonia 58
UZ - Uzbekistan 56
VE - Venezuela 56
MA - Marocco 51
BE - Belgio 46
CL - Cile 42
KE - Kenya 30
MY - Malesia 29
JO - Giordania 28
PY - Paraguay 28
BG - Bulgaria 27
EU - Europa 27
AU - Australia 26
CZ - Repubblica Ceca 26
TW - Taiwan 26
IR - Iran 23
TN - Tunisia 23
AE - Emirati Arabi Uniti 22
NP - Nepal 22
ET - Etiopia 21
DZ - Algeria 19
EG - Egitto 19
JM - Giamaica 19
PE - Perù 19
AZ - Azerbaigian 18
RO - Romania 17
UY - Uruguay 17
OM - Oman 16
CH - Svizzera 15
IL - Israele 14
LT - Lituania 14
PS - Palestinian Territory 14
TH - Thailandia 14
KZ - Kazakistan 13
BO - Bolivia 10
SN - Senegal 10
NZ - Nuova Zelanda 9
DO - Repubblica Dominicana 8
LB - Libano 8
MD - Moldavia 8
NO - Norvegia 8
RS - Serbia 8
BH - Bahrain 7
BY - Bielorussia 7
CR - Costa Rica 7
HU - Ungheria 7
KG - Kirghizistan 7
KW - Kuwait 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
GA - Gabon 6
MN - Mongolia 6
AL - Albania 5
GE - Georgia 5
GR - Grecia 5
GT - Guatemala 5
HN - Honduras 5
MM - Myanmar 5
NI - Nicaragua 5
SC - Seychelles 5
SY - Repubblica araba siriana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
PA - Panama 4
AM - Armenia 3
AO - Angola 3
Totale 58.586
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.259
Singapore 3.035
Woodbridge 2.789
Ashburn 2.530
Fairfield 2.114
Hong Kong 2.094
Houston 1.915
Chandler 1.335
Toronto 1.252
Jacksonville 1.216
Dublin 1.214
San Jose 1.130
Wilmington 1.002
Seattle 882
Frankfurt am Main 852
Cambridge 769
New York 698
Ho Chi Minh City 581
Dearborn 557
Princeton 534
Beijing 470
Santa Clara 457
Hanoi 452
Hefei 435
The Dalles 433
Chicago 427
Milan 416
Dallas 341
Los Angeles 318
Nanjing 293
Seoul 291
Lauterbourg 249
Lawrence 228
Council Bluffs 220
Altamura 204
Lachine 197
Shanghai 194
Buffalo 153
Helsinki 146
São Paulo 137
Moscow 134
San Diego 129
Boardman 123
Guangzhou 114
Vienna 89
Shenyang 88
Rome 87
Da Nang 86
Orem 84
Andover 76
Nanchang 76
Baghdad 75
Changsha 71
Tokyo 67
London 65
Ottawa 64
Hebei 63
Haiphong 62
Falls Church 57
Rio de Janeiro 57
Tianjin 57
Hangzhou 56
Columbus 50
Jiaxing 50
Johannesburg 49
Norwalk 49
Philadelphia 49
Brooklyn 47
Dong Ket 47
Munich 47
Chennai 46
Montreal 46
Fremont 45
Jakarta 45
Mountain View 45
Jinan 44
Tashkent 42
Boston 41
Nuremberg 41
Salt Lake City 41
Warsaw 41
Dhaka 40
Zhengzhou 38
Brasília 36
Brussels 36
Huizen 36
Pune 36
Hải Dương 35
Kunming 35
Denver 33
Belo Horizonte 32
Elk Grove Village 32
Can Tho 31
Phoenix 31
Lissone 29
Manchester 29
Mexico City 29
Redmond 29
Riyadh 29
San Francisco 28
Totale 39.088
Salva come PNG Salva come JPEG
Nome #
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma 666
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 515
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 486
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 448
JNK SIGNALING ACTIVATED BY PLATELET-DERIVED GROWTH FACTOR D (PDGF-D) STIMULATES SECRETION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C (VEGF-C) BY CANCER-ASSOCIATED FIBROBLASTS TO PROMOTE LYMPHANGIOGENESIS AND EARLY METASTATIZATION IN CHOLANGIOCARCINOMA 425
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 383
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 382
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 381
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 351
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 335
Health related quality of life in chronic liver diseases 320
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 318
Long term outcome of acute pancreatitis in Italy: Results of a multicentre study 316
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 312
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 312
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 311
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 309
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 306
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 303
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 302
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 296
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 296
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 295
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 295
The impact of liver disease on the health-related quality of life 291
Effect of Silibinin on biliary lipid composition. Experimental and clinical study 290
Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 285
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 284
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 283
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 282
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 282
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 281
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 281
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 279
Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale] 279
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 276
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 275
Cholangiocyte biology as relevant to cystic liver diseases 273
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 273
Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice 270
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 268
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 268
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 267
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 266
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 266
Health Related Quality of Life in the Major Liver Conditions 265
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 264
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 263
Models of The Impact of Major Liver Diseases on Eq-5d Visual Analogue Scale and Utility-Index: Convergences and Divergences 261
Liver-allocation policies for patients affected by HCC in Europe 259
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice 258
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 258
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the " Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 257
Difference in health related quality of life of chronic liver diseases and general population 256
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 255
The challenges of primary biliary cholangitis: What is new and what needs to be done 255
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. 254
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 253
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 252
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 252
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 252
Functional anatomy of normal bile ducts 251
Foxa1 and Foxa2 regulate bile duct development in mice 250
Continuous subcutaneous insulin infusion in Italy: Third national survey 250
The cholangiopathies: disorders of biliary epithelia 249
Effect of age on single- and multiple-dose pharmacokinetics of erythromycin 249
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4NF-κB-mediated inflammatory response in mice 249
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 248
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 248
pka-dependent p-ser- 675 β-catenin phosphorylation increases cholangiocyte motility in pkhd1del4/del4 mice, a model of fibropolycystic liver diseases caused by defective fibrocystin function 248
Cholangiocyte pathobiology 248
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 246
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 246
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 246
Effect of Silybin on biliary lipid composition in rats 245
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 245
Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19 244
Intracellular alkalinization stimulates bile flow and vesicular-mediated exocytosis in IPRL 243
"The city of Hepar": Rituals, gastronomy, and politics at the origins of the modern names for the liver 242
Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview 241
JNK SIGNALING ACTIVATED BY PLATELET-DERIVED GROWTH FACTOR D (PDGF-D) STIMULATES SECRETION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C (VEGF-C) BY CANCER-ASSOCIATED FIBROBLASTS TO PROMOTE LYMPHANGIOGENESIS AND EARLY METASTASIZATION IN CHOLANGIOCARCINOMA 238
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice 238
Β-Catenin-Mediated Cxcl1 and Cxcl10 Secretion by Fibrocystin-Defective Cholangiocytes Regulates Peribiliary Recruitment of Fibrocytes in Congenital Hepatic Fibrosis 238
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib 237
Sorafenib paradoxically activates the raf/mek/erk signaling in mice with polycystic liver disease (pld) caused by conditional deletion of polycystin-2 237
Pka-dependent p-ser-675-catenin phosphorylation increases cholangiocyte motility in a mouse model of fibropolycystic liver diseases 237
Animal models of cholestasis: An update on inflammatory cholangiopathies 237
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 236
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 236
Intracellular pH regulation in isolated rat bile duct epithelial cells 235
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 234
Notch signaling and progenitor/ductular reaction in steatohepatitis 232
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 232
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population 231
Altered store operated calcium entry increases cAMP production and ERK1/2 phosphorylation in Polycystin-2 defective cholangiocytes 231
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 230
Vascular biology of the biliary epithelium 230
Effect of ursodeoxycholic acid on intracellular pH in a bile duct epithelium-like cell line 229
Effect of UDCA on intracellular and biliary pH in isolated rat hepatocyte couplets and perfused livers 229
Purinergic regulation of acid/base transport in human and rat biliary epithelial cell lines. 229
Totale 27.960
Salva come PNG Salva come JPEG
Categoria #
all - tutte 192.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 192.867
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021577 0 0 0 0 0 0 0 0 0 0 274 303
2021/20222.877 130 293 499 219 101 210 133 197 143 199 244 509
2022/20235.338 594 1.602 470 404 435 810 72 278 369 31 178 95
2023/20243.783 151 142 112 179 505 1.038 764 139 333 33 24 363
2024/20258.323 551 1.073 423 324 775 275 522 405 757 1.178 652 1.388
2025/202618.974 2.210 1.393 1.359 1.726 2.090 1.183 2.554 1.068 1.823 1.932 1.636 0
Totale 59.655